Skip to content
Tenfell
Upcoming
Published 23 Jan 2026

NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide

NHS England · London

Key facts

Estimated value
£196,203,120
Engagement closes
30 Jan 2026
Contract ends
31 May 2028
Buyer type
Central government

Description

NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months. Periods of call-offs under the framework agreement: CM/PHG/24/5716/01– Hospital Only Products - Lenalidomide CESW: (Midlands and Southwest): 1st June 2026 – 31st May 2028 NWLN: (Northwest and London North): 1st June 2026 – 31st May 2028 LSNE: (London South and Northeast): 1st June 2026 – 31st May 2028 CM/PHG/24/5716/02 – Hospital Only Products - Pomalidomide CESW: (Midlands and Southwest): 1st June 2026 – 31st May 2028 NWLN: (Northwest and London North): 1st June 2026 – 31st May 2028 LSNE: (London South and Northeast): 1st June 2026 – 31st May 2028 CM/PHG/24/5716/03 – Hospital Only Products - Thalidomide CESW: (Midlands and Southwest): 1st June 2026 – 31st May 2028 NWLN: (Northwest and London North): 1st June 2026 – 31st May 2028 LSNE: (London South and Northeast): 1st June 2026 – 31st May 2028

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Find a Tender (Open Government Licence v3.0). Always read the original notice before responding.